Authored by Mayasari Lim, Ph.D. Industry sponsored MSC-based clinical trial activities for COVID-19 As of this writing, more than a dozen companies and groups have announced their interests to develop ... More
Authored by Jonathan Carson, PhD “If you can’t fly then run, if you can’t run then walk, if you can’t walk then crawl, but whatever you do you have to ... More
Authored by Mayasari Lim, PhD, Jonathan Carson, PhD, and Jon A. Rowley, PhD, RoosterBio, Inc. Some research suggests that ARDS might be treatable with the secretome of MSCs. Scientists and ... More
Authored by Mayasari Lim | West Coast and APAC lead for RoosterBio Amidst the scramble and panic-buying that some of us are experiencing, several treatments to combat this novel ... More
Originally Authored by Jon A. Rowley, PhD, Founder (February 15, 2014). Updated by Iain Farrance, PhD and Jon Carson, PhD (February 5, 2020) What’s in a Name? MSC is the common ... More
Originally Published: July 7, 2014 Updated October 2019 by: Taby Ahsan, Ph.D., Vice President of Analytical, Process & Product Development & Katrina Adlerz, Ph.D., Scientist, Development What is Population Doubling Level ... More
Authored by Iain Farrance, PhD, Technical Marketing Associate Introduction Human mesenchymal stromal cells (hMSC) are considered the “workhorse” of Regenerative Medicine (RegenMed). hMSC are a critical starting material in a growing variety of ... More
Human Mesenchymal Stem/Stromal Cells (hMSCs), from bone marrow or other tissues, are poised to have the most significant impact on Regenerative Medicine compared to any other single cell type. This ... More
INTRODUCTION: Human mesenchymal stem cells (hMSC) are currently in use in over 400 clinical trials and are critical components of tomorrow’s cell-based products and devices (1, 2, 3). The secretion ... More
INTRODUCTION: Human Mesenchymal Stem/Stromal Cells, or hMSC, are key components of future therapeutics, engineered tissues, and medical devices and are currently in use in over 400 clinical trials (1). ... More